前列腺癌骨转移的治疗进展及疗效评价

被引：18

作者：

董世强

柳青

徐子寒

杨智凯

连通

李伯文

王海涛

机构：

[1] 天津医科大学第二医院肿瘤科天津市泌尿外科研究所

来源：

肿瘤 | 2019年 / 07期

关键词：

前列腺肿瘤; 肿瘤转移,骨; 实体肿瘤疗效评价标准;

D O I：

暂无

中图分类号：

R737.25 [前列腺肿瘤];

学科分类号：

100214 [肿瘤学];

摘要：

前列腺癌骨转移在临床中十分常见。伴随骨转移而来的骨痛、病理性骨折和转移性硬膜外脊髓压迫等并发症严重影响着前列腺癌患者的生活质量,缩短患者的总体生存期,增加患者的经济负担。因此,唯有切实有效的全身治疗联合针对性的抗骨转移治疗才能减少上述并发症的发生,从而延长患者的总体生存期。目前,针对前列腺癌骨转移的治疗方式多种多样,但对于前列腺癌单纯骨转移患者治疗后的疗效评价尚无统一的标准。为了更加方便地选择最佳的治疗方案,以及准确地进行疗效评价以及时调整治疗方案,本文就目前前列腺癌骨转移的常用治疗方式、最新研究成果和主流的疗效评价标准进行综述。

引用

页码：573 / 581

页数：9

共 25 条

[1]

Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis[J] Yuta Nakai;Kazuo Okamoto;Asuka Terashima;Shogo Ehata;Jun Nishida;Takeshi Imamura;Takashi Ono;Hiroshi Takayanagi; Bone Research 2019, 01

[2]

2015年中国分地区恶性肿瘤发病和死亡分析 [J].

孙可欣 ;

郑荣寿 ;

张思维 ;

曾红梅 ;

邹小农 ;

陈茹 ;

顾秀瑛 ;

魏文强 ;

赫捷 .

中国肿瘤, 2019, 28 (01) :1-11

[3]

骨转移瘤患者生活质量评估的研究进展 [J].

赵志庆 ;

叶志鹏 ;

燕太强 ;

郭卫 ;

杨荣利 ;

汤小东 .

中华骨科杂志, 2017, 37 (18)

[4]

Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives[J] Maarten J. van der Doelen;Niven Mehra;Rick Hermsen;Marcel J.R. Janssen;Winald R. Gerritsen;Inge M. van Oort Clinical Genitourinary Cancer 2019,

[5]

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J] Freddie Bray BSc; MSc; PhD;Jacques Ferlay ME;Isabelle Soerjomataram MD; MSc; PhD;Rebecca L. Siegel MPH;Lindsey A. Torre MSPH;Ahmedin Jemal PhD; DVM CA: A Cancer Journal for Clinicians 2018,

[6]

CT temporal subtraction method for detection of sclerotic bone metastasis in the thoracolumbar spine[J] Midori Ueno;Takatoshi Aoki;Seiichi Murakami;Hyoungseop Kim;Takashi Terasawa;Akitaka Fujisaki;Yoshiko Hayashida;Yukunori Korogi European Journal of Radiology 2018,

[7]

Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT‐BSI) study[J] Kenichi Nakajima;Go Kaneko;Satoru Takahashi;Hideyasu Matsuyama;Hiroaki Shiina;Tomohiko Ichikawa;Hiroyuki Horikoshi;Katsuyoshi Hashine;Yutaka Sugiyama;Takeshi Miyao;Manabu Kamiyama;Kenichi Harada;Akito Ito;Atsushi Mizokami International Jou

[8]

Novel three-dimensional bone ‘mapping’ software can help assess progression of osseous metastases from routine CT[J] D. Thurtle;G. M. Treece;T. Barrett;V. J. Gnanapragasam Radiation Oncology 2017,

[9]

Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone[J] Mikhail G. Kolonin;Anna Sergeeva;Daniela I. Staquicini;Tracey L. Smith;Christy A. Tarleton;Jeffrey J. Molldrem;Richard L. Sidman;Serena Marchio?;Renata Pasqualini;Wadih Arap Cancer Research 2017,

[10]

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing; Metastatic; and Castration-Resistant Prostate Cancer[J] Philip Cornford;Joaquim Bellmunt;Michel Bolla;Erik Briers;Maria De Santis;Tobias Gross;Ann M. Henry;Steven Joniau;Thomas B. Lam;Malcolm D. Mason;Henk G. van der Poel;Theo H. van der Kwast;Olivier Rouvière;Thomas Wiegel;Nicolas Mottet European Urology 2017,

← 1 2 3 →